Andere Sprachen Aptamer Group plc

Aktien

A3DB1Q

GB00BNRRP542

APTA

Verzögert London S.E. Andere Börsenplätze 12:16:10 08.05.2024			% 5 Tage	% 1. Jan.
0,615 ^GBX	-12,14 %		-8,89 %	-46,52 %

22.04.	GEWINNE UND HANDEL: Zenovas Kitemark-Auszeichnung; Carnivals Augen sparen	AN
18.04.	Aptamer schließt neue Partnerschaft für Optimer+-Transplantatabstoßungstherapie ab	AN

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

EARNINGS AND TRADING: Zenova's Kitemark award; Carnival's eyes savings	22.04.
Aptamer inks new Optimer+ transplant rejection therapy partnership	18.04.
Aptamer Group, Kairos Biotech Team Up to Improve Transplant Success	18.04.
Aptamer Group Files Patent Application for Optimer Binders	08.04.
Aptamer submits patent application for Optimer binders	08.04.
EARNINGS AND TRADING: Arbuthnot ups payout as profit more than doubles	28.03.
Aptamer Group plc Reports Earnings Results for the Half Year Ended December 31, 2023	28.03.
Zentek Says Potential COVID-19 Drug Shows 'Promising' Safety Profile in Preclinical Trial	25.03.
Aptamer shares jump on successful Unilever contract progression	11.03.
Aptamer Group, Unilever Prepare to Patent Optimers Developed Under Partnership	11.03.
Aptamer says new Optimer+ delivers improved results	27.02.
Aptamer Group plc Announces R&D Progress on New Optimer®? + Platform	27.02.
Aptamer and Neuro-Bio begin Alzheimer's test development second phase	22.02.
Aptamer Group, Neuro-Bio Enter Second Phase of Partnership for Alzheimer's Flow Test Development	22.02.
Aptamer shares plunge as half-year revenue to fall by 70%	05.02.
Aptamer Group plc Provides Revenue Guidance for the First Half of the Fiscal Year 2024	05.02.
Zentek Announces "Positive" Therapeutic Results Achieved by Triera Biosciences for C19HBA	30.01.
Ribomic and Ajinomoto Co. Partner for Nucleic Acid Aptamer Research	17.01.
Ribomic Enters Into Drug Research Collaboration with Ajinomoto	17.01.
Aptamer inks deal for Optimer discovery with biotech firm	14.12.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Aptamer Group plc

Aktien

A3DB1Q

GB00BNRRP542

APTA

Andere Sprachen

Filter